BNP Paribas Financial Markets’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Buy
70,812
+26,056
+58% +$623K ﹤0.01% 2816
2025
Q4
$1.2M Sell
44,756
-10,792
-19% -$258K ﹤0.01% 2979
2025
Q3
$1.19M Sell
55,548
-21,206
-28% -$502K ﹤0.01% 3009
2025
Q2
$1.66M Sell
76,754
-160,656
-68% -$2.99M ﹤0.01% 2602
2025
Q1
$3.94M Sell
237,410
-51,061
-18% -$928K ﹤0.01% 1959
2024
Q4
$5.29M Buy
288,471
+64,853
+29% +$1.05M ﹤0.01% 1737
2024
Q3
$3.44M Buy
223,618
+161,331
+259% +$2.69M ﹤0.01% 1721
2024
Q2
$1.01M Sell
62,287
-57,858
-48% -$934K ﹤0.01% 2275
2024
Q1
$2.22M Sell
120,145
-109,620
-48% -$2.72M ﹤0.01% 1989
2023
Q4
$7.19M Sell
229,765
-75,403
-25% -$1.8M 0.01% 1215
2023
Q3
$6.36M Buy
305,168
+7,745
+3% +$210K 0.01% 1114
2023
Q2
$7.12M Buy
297,423
+28,297
+11% +$629K 0.01% 1060
2023
Q1
$5.06M Buy
269,126
+123,752
+85% +$2.36M 0.01% 1242
2022
Q4
$2.31M Sell
145,374
-42,789
-23% -$669K 0.01% 1687
2022
Q3
$3.08M Buy
188,163
+133,376
+243% +$2.16M 0.01% 1649
2022
Q2
$772K Sell
54,787
-34,132
-38% -$637K ﹤0.01% 2380
2022
Q1
$2.15M Buy
88,919
+18,371
+26% +$445K ﹤0.01% 1763
2021
Q4
$1.65M Buy
70,548
+12,812
+22% +$258K ﹤0.01% 2206
2021
Q3
$959K Buy
57,736
+20,443
+55% +$394K ﹤0.01% 2396
2021
Q2
$910K Buy
37,293
+11,809
+46% +$267K ﹤0.01% 2237
2021
Q1
$657K Buy
25,484
+5,576
+28% +$245K ﹤0.01% 2413
2020
Q4
$1.06M Buy
19,908
+3,750
+23% +$186K ﹤0.01% 1985
2020
Q3
$667K Sell
16,158
-22,841
-59% -$986K ﹤0.01% 2045
2020
Q2
$1.89M Sell
38,999
-35,037
-47% -$1.68M ﹤0.01% 1520
2020
Q1
$3.13M Buy
74,036
+38,320
+107% +$1.58M 0.01% 1226
2019
Q4
$1.53M Sell
35,716
-11,467
-24% -$499K 0.01% 1811
2019
Q3
$1.7M Buy
47,183
+3,380
+8% +$102K 0.01% 1599
2019
Q2
$1.17M Sell
43,803
-15,322
-26% -$391K ﹤0.01% 1681
2019
Q1
$1.59M Buy
59,125
+25,189
+74% +$588K 0.01% 1498
2018
Q4
$549K Sell
33,936
-14,363
-30% -$279K ﹤0.01% 1774
2018
Q3
$1M Buy
48,299
+7,503
+18% +$118K ﹤0.01% 1750
2018
Q2
$623K Buy
40,796
+14,138
+53% +$252K ﹤0.01% 1918
2018
Q1
$599K Buy
26,658
+7,926
+42% +$219K ﹤0.01% 2079
2017
Q4
$564K Sell
18,732
-4,894
-21% -$157K ﹤0.01% 2384
2017
Q3
$890K Buy
23,626
+2,489
+12% +$81K ﹤0.01% 1633
2017
Q2
$590K Buy
21,137
+2,038
+11% +$60.7K ﹤0.01% 1826
2017
Q1
$657K Sell
19,099
-3,352
-15% -$118K ﹤0.01% 1591
2016
Q4
$647K Buy
22,451
+2,711
+14% +$71.7K ﹤0.01% 1548
2016
Q3
$628K Sell
19,740
-914
-4% -$31K ﹤0.01% 1110
2016
Q2
$670K Buy
20,654
+20,591
+32,684% +$689K ﹤0.01% 1362
2016
Q1
$1.76K Sell
63
-16,323
-100% -$356K ﹤0.01% 2435
2015
Q4
$584K Buy
16,386
+247
+2% +$8.7K ﹤0.01% 1294
2015
Q3
$534K Buy
16,139
+9,508
+143% +$396K ﹤0.01% 1318
2015
Q2
$278K Buy
6,631
+4,754
+253% +$184K ﹤0.01% 1568
2015
Q1
$61.2K Buy
+1,877
New +$64.5K ﹤0.01% 1862
2014
Q4
Sell
-4,740
Closed -$117K 1990
2014
Q3
$117K Buy
4,740
+4,387
+1,243% +$103K ﹤0.01% 2097
2014
Q2
$7.97K Buy
353
+287
+435% +$5.99K ﹤0.01% 2411
2014
Q1
$1.33K Sell
66
-844
-93% -$21.4K ﹤0.01% 2779
2013
Q4
$22.7K Sell
910
-18,398
-95% -$434K ﹤0.01% 2192
2013
Q3
$530K Sell
19,308
-8,991
-32% -$188K ﹤0.01% 1501
2013
Q2
$514K Buy
+28,299
New +$390K ﹤0.01% 1526

Other funds holding ACAD